Literature DB >> 14663835

Increased nuchal translucency and congenital heart defects in a low-risk population.

E Hafner1, T Schuller, M Metzenbauer, K Schuchter, K Philipp.   

Abstract

OBJECTIVE: Increased first-trimester nuchal translucency (NT) is a possible marker for congenital heart defects in euploid fetuses. In this study, we wanted to determine the sensitivity for congenital heart defects using the 95th centile of the NT as a cut-off point.
METHODS: All women who booked for delivery in our hospital in the first trimester underwent NT measurement at a crown-rump length (CRL) of between 35 and 75 mm. In all euploid fetuses and newborns with isolated or associated CHD, NT was examined retrospectively and classified as normal (<95th centile according to CRL-dependent centiles in our own data) or increased (> or =95th centile).
RESULTS: From a total of 12,978 euploid fetuses screened, 27 had CHD (22 isolated and 5 cases associated with additional malformations). Moreover, 7 of the 27 fetuses also had increased NT (26%). Increased NT was significantly more frequent in fetuses with associated CHD (4/5) than in those with isolated CHD (3/22, Yates corrected chi2 p=0.012). In fact, the relative risk for CHD was 6.6 times higher in fetuses with increased NT compared to those with normal NT.
CONCLUSION: Increased NT for the detection of CHD performed less well than in other studies. Nevertheless, it can be used as an indication for fetal echocardiography. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2003        PMID: 14663835     DOI: 10.1002/pd.721

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  2 in total

1.  Increased nuchal traslucency in normal karyotype fetuses.

Authors:  Roberta De Domenico; Marianna Faraci; Entela Hyseni; Fosca A F Di Prima; Oriana Valenti; Santo Monte; Elsa Giorgio; Eliana Renda
Journal:  J Prenat Med       Date:  2011-04

Review 2.  Fetal echocardiography: where are we?

Authors:  Anita Saxena; N Reeni Soni
Journal:  Indian J Pediatr       Date:  2005-07       Impact factor: 1.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.